Results 121 to 130 of about 638,486 (297)
Dynamics of an SIS Model on Homogeneous Networks with Delayed Reduction of Contact Numbers
During infectious disease outbreaks, people may modify their contact patterns after realizing the risk of infection. In this paper, we assume that individuals make the decision of reducing a fraction of their links when the density of infected ...
Maoxing Liu, Gergely Rost
doaj +1 more source
Zuranolone: A case study in (regulatory) rush to judgement?
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove +4 more
wiley +1 more source
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer +4 more
wiley +1 more source
The relevance of this study stems from the growing importance of modelling not only the biological transmission of infectious diseases but also the behavioural and informational factors that shape real-world epidemic dynamics. The subject of the research
Dmytro Chumachenko
doaj +1 more source
SpyCatcher‐mi3 nanoparticles displaying RBD‐SD1 from MERS‐CoV, NL140422, and HKU4 elicited robust and cross‐reactive IgG responses in mice. Only MERS‐CoV RBD‐SD1 induced neutralizing antibodies against MERS‐CoV and protected human DPP4 mice from a MERS‐CoV challenge, indicating conserved serologic but limited cross‐neutralizing epitopes.
Peter J. Halfmann +9 more
wiley +1 more source
Mathematical modelling of COVID-19 dynamics using SVEAIQHR model
In this study, we formulate an eight-compartment mathematical model with vaccination as one of the compartments to analyze the dynamics of COVID-19 transmission.
Venkatesh Ambalarajan +4 more
doaj +1 more source
Inferring how an epidemic will progress and what actions to take when presented with limited information is of critical importance for epidemiologists and health professionals. In real world settings, epidemiology data can be scarce or subject to reporting errors. In this project there are different epidemic scenarios simulated and, using hidden Markov
openaire +2 more sources
The impacts of biological invasions
ABSTRACT The Anthropocene is characterised by a continuous human‐mediated reshuffling of the distributions of species globally. Both intentional and unintentional introductions have resulted in numerous species being translocated beyond their native ranges, often leading to their establishment and subsequent spread – a process referred to as biological
Phillip J. Haubrock +42 more
wiley +1 more source
ProTides for Antiviral Activity Beyond Liver Cells
A strategy for obtaining prodrugs of antiviral nucleotides with broad tissue activity is presented that relies on cycloalkyl or cycloalkylalkyl esters, improving uptake and esterase cleavage, and producing nanomolar inhibitors in kidney, colon, and lung cells.
Felix Goebel +5 more
wiley +1 more source
Numerical analysis of dengue transmission model using Caputo–Fabrizio fractional derivative
This study demonstrates the use of fractional calculus in the field of epidemiology, specifically in relation to dengue illness. Using noninteger order integrals and derivatives, a novel model is created to examine the impact of temperature on the ...
Alshehry Azzh Saad +3 more
doaj +1 more source

